This is a document about treatment of scar
This document provides clinical practice guidelines for the treatment of keloid disorders using intra-lesional triamcinolone (ILT). It addresses the common use of ILT, discussing the risks associated with high-dose formulations like Kenalog-40 and recommending the use of diluted Kenalog-10 to minimize side effects.
The author recommends Gauge 30 needles for injection of ILT to avoid introducing new injury to the keloid.
Injections should be repeated every 3-4 weeks until maximum response is achieved, with intervals adjusted based on the longevity of the benefit.
The author's practice is to dilute Kenalog-10 with normal saline in a ratio of 1 to 5, resulting in a 20% final product dilution.